2002
DOI: 10.1017/s1355838202022069
|View full text |Cite
|
Sign up to set email alerts
|

Puromycin oligonucleotides reveal steric restrictions for ribosome entry and multiple modes of translation inhibition

Abstract: Peptidyl transferase inhibitors have generally been studied using simple systems and remain largely unexamined in in vitro translation extracts. Here, we investigate the potency, product distribution, and mechanism of various puromycin-oligonucleotide conjugates (1 to 44 nt with 39-puromycin) in a reticulocyte lysate cell-free translation system. Surprisingly, the potency decreases as the chain length of the oligonucleotide is increased in this series, and only very short puromycin conjugates function efficien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
17
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 34 publications
4
17
0
Order By: Relevance
“…In our in vitro experiment, 6 mM puromycin inhibited approximately half of ORI5 substrate cleavage by MtMRP, and half of the ORI5 substrate cleavage activities by NuMRP were inhibited at 8 mM puromycin (Table 2). This is a concentration 1000-fold higher than that found to inhibit the ribosome (Starck and Roberts 2002), and equivalent to what was seen for the mouse RNase MRP and P enzymes (Potuschak et al 1993). This confirms puromycin as an inhibitor of RNase MRP but revealed no significant enzymatic differences between the two enzymes.…”
Section: Inhibitors Of Rnase Mrpsupporting
confidence: 52%
“…In our in vitro experiment, 6 mM puromycin inhibited approximately half of ORI5 substrate cleavage by MtMRP, and half of the ORI5 substrate cleavage activities by NuMRP were inhibited at 8 mM puromycin (Table 2). This is a concentration 1000-fold higher than that found to inhibit the ribosome (Starck and Roberts 2002), and equivalent to what was seen for the mouse RNase MRP and P enzymes (Potuschak et al 1993). This confirms puromycin as an inhibitor of RNase MRP but revealed no significant enzymatic differences between the two enzymes.…”
Section: Inhibitors Of Rnase Mrpsupporting
confidence: 52%
“…This observation is consistent with the molecules being stable in FBS over the 4 h incubation time. On the other hand, in vitro translated Pep1 (natural carboxy C-terminus and therefore sensitive to carboxypeptidase degradation) 24 shows a distinctly lower signal in FBS versus assay buffer, consistent with peptide degradation. Overall, our results show that C-terminally blocked peptides (fusions and amidated peptides) show excellent performance in 1% FBS and argue that these reagents can be used in complex media-containing proteases and peptidases.
Figure 5Peptides have modification-dependent stability in serum.
…”
Section: Resultsmentioning
confidence: 96%
“…(Fig. 2B) It has been shown that puromycin substituted at the 5 0 OH has decreased efficacy as a translation inhibitor, so a deoxycytidine (dC) was used to link fluorescent dyes (Cy5 and fluorescein) to puromycin (Starck and Roberts 2002;Starck et al 2004). Fluorescein-dC-puromycin (F2P) has been used to measure global protein synthesis in the dendrites of rat hippocampal neurons.…”
Section: Fluorescent Puromycin Derivativesmentioning
confidence: 99%